Logo image of HCHC

Hc2 Holdings Inc (HCHC) Stock Fundamental Analysis

NYSE:HCHC - New York Stock Exchange, Inc. -

3.68  +0.02 (+0.55%)

After market: 3.68 0 (0%)

Fundamental Rating

1

HCHC gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 52 industry peers in the Construction & Engineering industry. Both the profitability and financial health of HCHC have multiple concerns. HCHC is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

HCHC had negative earnings in the past year.

1.2 Ratios

Industry RankSector Rank
ROA -0.47%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM 0.5%
PM (TTM) -3.1%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

More info and screens

1

2. Health

2.1 Basic Checks

There is no outstanding debt for HCHC. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

HCHC has an Altman-Z score of 0.16. This is a bad value and indicates that HCHC is not financially healthy and even has some risk of bankruptcy.
HCHC has a Debt/Equity ratio of 1.19. This is a high value indicating a heavy dependency on external financing.
Industry RankSector Rank
Debt/Equity 1.19
Debt/FCF N/A
Altman-Z 0.16
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

HCHC has a Current Ratio of 1.10. This is a normal value and indicates that HCHC is financially healthy and should not expect problems in meeting its short term obligations.
HCHC has a Quick Ratio of 1.10. This is a normal value and indicates that HCHC is financially healthy and should not expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 1.1
Quick Ratio 1.1

More info and screens

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 25.53% over the past year.
The Revenue for HCHC has decreased by -43.51% in the past year. This is quite bad
HCHC shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -2.14% yearly.
EPS 1Y (TTM)25.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-211.54%
Revenue 1Y (TTM)-43.51%
Revenue growth 3Y-14.94%
Revenue growth 5Y-2.14%
Sales Q2Q%-35.33%

3.2 Future

Based on estimates for the next years, HCHC will show a very strong growth in Earnings Per Share. The EPS will grow by 32.00% on average per year.
Based on estimates for the next years, HCHC will show a very negative growth in Revenue. The Revenue will decrease by -40.49% on average per year.
EPS Next Y99.36%
EPS Next 2Y51.66%
EPS Next 3Y32%
EPS Next 5YN/A
Revenue Next Year42.23%
Revenue Next 2Y-46.63%
Revenue Next 3Y-40.49%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
HCHC Yearly Revenue VS EstimatesHCHC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 1B 2B 3B 4B
HCHC Yearly EPS VS EstimatesHCHC Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 0 1 -1 2 3

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for HCHC. In the last year negative earnings were reported.
HCHC is valuated correctly with a Price/Forward Earnings ratio of 12.27.
HCHC's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 21.76.
Industry RankSector Rank
PE N/A
Fwd PE 12.27
HCHC Price Earnings VS Forward Price EarningsHCHC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 24.54
HCHC Per share dataHCHC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as HCHC's earnings are expected to grow with 32.00% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y51.66%
EPS Next 3Y32%

More info and screens

0

5. Dividend

5.1 Amount

HCHC does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Hc2 Holdings Inc

NYSE:HCHC (9/17/2021, 8:04:00 PM)

After market: 3.68 0 (0%)

3.68

+0.02 (+0.55%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.11%
Inst Owner Change-34.64%
Ins Owners11.39%
Ins Owner Change0%
Market Cap286.38M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 12.27
P/S 0.27
P/FCF N/A
P/OCF N/A
P/B 0.56
P/tB N/A
EV/EBITDA 24.54
EPS(TTM)-1.05
EYN/A
EPS(NY)0.3
Fwd EY8.15%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS13.63
BVpS6.57
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.47%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 0.5%
PM (TTM) -3.1%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.15
Health
Industry RankSector Rank
Debt/Equity 1.19
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.1
Quick Ratio 1.1
Altman-Z 0.16
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)25.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-211.54%
EPS Next Y99.36%
EPS Next 2Y51.66%
EPS Next 3Y32%
EPS Next 5YN/A
Revenue 1Y (TTM)-43.51%
Revenue growth 3Y-14.94%
Revenue growth 5Y-2.14%
Sales Q2Q%-35.33%
Revenue Next Year42.23%
Revenue Next 2Y-46.63%
Revenue Next 3Y-40.49%
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A